SLDB
Solid Biosciences Inc. · Healthcare · Market cap $915.7M
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.7M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Jul 7, 2026
Hanrahan Jessie
Solid Biosciences Inc. (SLDB) has 34 SEC Form 4 filings (61 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jul 7, 2026.
Inside the rolling window, 7 insiders at Solid Biosciences Inc. reported no open-market purchases and 28 open-market sales totaling $2.7M. The most active filer is Director Ganot Ilan with 5 filings. Insiders have net sold $2.5M over the trailing 6 months. The most recent open-market filing is a sale of 4,134 shares by Chief Regulatory Officer Hanrahan Jessie, dated Feb 18, 2026, worth $24K.
- Industry:Biotechnology
- CEO:Alexander G. Cumbo
- Employees:121
- HQ:Charlestown, MA, US
- IPO:2018-01-26
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Chief Regulatory Officer | Sale | 4,134 | $24K | Feb 18 | +44.3% | SEC ↗ | |
| Director | Sale | 2,658 | $15K | Feb 18 | +44.3% | SEC ↗ | |
| CFO & Treasurer | Sale | 5,404 | $31K | Feb 18 | +44.3% | SEC ↗ | |
| President and CEO | Sale | 16,644 | $97K | Feb 18 | +44.3% | SEC ↗ | |
| Chief Technology Officer | Sale | 3,616 | $21K | Feb 18 | +44.3% | SEC ↗ | |
| Chief Operating Officer | Sale | 7,469 | $43K | Feb 18 | +44.3% | SEC ↗ | |
| Chief Technology Officer | Sale | 10,905 | $70K | Feb 6 | +31.0% | SEC ↗ | |
| Chief Regulatory Officer | Sale | 12,348 | $80K | Feb 6 | +31.0% | SEC ↗ | |
| Director | Sale | 7,205 | $46K | Feb 6 | +31.0% | SEC ↗ | |
| Chief Medical Officer | Sale | 12,616 | $81K | Feb 6 | +31.0% | SEC ↗ | |
| CFO & Treasurer | Sale | 14,783 | $95K | Feb 6 | — | SEC ↗ | |
| President and CEO | Sale | 48,913 | $315K | Feb 6 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 18,894 | $122K | Feb 6 | — | SEC ↗ | |
| Chief Operating Officer | Sale | 37,771 | $243K | Feb 2 | — | SEC ↗ | |
| Chief Technology Officer | Sale | 26,250 | $169K | Feb 2 | — | SEC ↗ | |
| Chief Regulatory Officer | Sale | 26,535 | $171K | Feb 2 | — | SEC ↗ | |
| CFO & Treasurer | Sale | 26,837 | $173K | Feb 2 | — | SEC ↗ | |
| President and CEO | Sale | 80,258 | $517K | Feb 2 | — | SEC ↗ | |
Brooks GabrielFirst in 3 months | Chief Medical Officer | Sale | 28,335 | $182K | Feb 2 | — | SEC ↗ |
| Director | Sale | 191 | $1K | Jan 30 | — | SEC ↗ | |
Tan KevinFirst filing | CFO & Treasurer | Sale | 5,704 | $30K | Jan 13 | — | SEC ↗ |
| Director | Sale | 1,053 | $6K | Jan 6 | — | SEC ↗ | |
Hanrahan JessieFirst filing | Chief Regulatory Officer | Sale | 4,483 | $23K | Dec 4 | — | SEC ↗ |
Howton David TFirst filing | Chief Operating Officer | Sale | 4,932 | $25K | Dec 4 | — | SEC ↗ |
Herzich PaulFirst filing | Chief Technology Officer | Sale | 2,701 | $14K | Dec 4 | — | SEC ↗ |
Frequently asked questions
How many SEC Form 4 insider filings does SLDB have?
Solid Biosciences Inc. (SLDB) has 34 SEC Form 4 filings (61 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Jul 7, 2026.
When was the most recent SEC Form 4 filing for SLDB?
The most recent Form 4 filing for SLDB on Tracefour is dated Jul 7, 2026.
Who is the most active insider at SLDB?
The most active SEC Form 4 filer at SLDB in the rolling window is Director Ganot Ilan, with 5 filings.
What is the net insider flow at SLDB over the last 6 months?
Over the trailing 180 days, insiders at SLDB have net sold $2.5M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at SLDB in the current window?
Inside the rolling window, insiders at SLDB bought $0 and sold $2.7M based on SEC Form 4 filings.
Can I get alerts for SLDB insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Solid Biosciences Inc. (SLDB). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Solid Biosciences Inc. is in the Healthcare sector.